China: Market for Medicaments Of Alkaloids Or Derivatives Thereof 2022

Market Size for Medicaments Of Alkaloids Or Derivatives Thereof in China

In 2021, the Chinese market for medicaments of alkaloids or derivatives thereof decreased by -X% to $X for the first time since 2014, thus ending a six-year rising trend. Over the period under review, consumption, however, saw a prominent increase. Over the period under review, the market attained the peak level at $X in 2020, and then reduced in the following year.

Production of Medicaments Of Alkaloids Or Derivatives Thereof in China

In value terms, production of medicaments of alkaloids or derivatives thereof declined to $X in 2021 estimated in export price. Over the period under review, production, however, posted a strong increase. The pace of growth appeared the most rapid in 2017 with an increase of X% against the previous year. Over the period under review, production of attained the peak level at $X in 2020, and then contracted in the following year.

Exports of Medicaments Of Alkaloids Or Derivatives Thereof

Exports from China

In 2021, after three years of growth, there was decline in overseas shipments of medicaments of alkaloids or derivatives thereof, when their volume decreased by -X% to X tons. The total export volume increased at an average annual rate of +X% over the period from 2012 to 2021; however, the trend pattern indicated some noticeable fluctuations being recorded throughout the analyzed period. The most prominent rate of growth was recorded in 2018 with an increase of X%. The exports peaked at X tons in 2020, and then reduced slightly in the following year.

In value terms, exports of medicaments of alkaloids or derivatives thereof reduced to $X in 2021. Over the period under review, exports, however, enjoyed a prominent increase. The pace of growth was the most pronounced in 2020 with an increase of X% against the previous year. As a result, the exports reached the peak of $X, and then fell in the following year.

Exports by Country

Japan (X tons) was the main destination for exports of medicaments of alkaloids or derivatives thereof from China, with a X% share of total exports. Moreover, exports of medicaments of alkaloids or derivatives thereof to Japan exceeded the volume sent to the second major destination, Democratic Republic of the Congo (X tons), sixfold. Ethiopia (X tons) ranked third in terms of total exports with a X% share.

From 2012 to 2021, the average annual growth rate of volume to Japan stood at +X%. Exports to the other major destinations recorded the following average annual rates of exports growth: Democratic Republic of the Congo (+X% per year) and Ethiopia (+X% per year).

In value terms, Japan ($X) remains the key foreign market for medicaments of alkaloids or derivatives thereof exports from China, comprising X% of total exports. The second position in the ranking was held by the United Arab Emirates ($X), with a X% share of total exports. It was followed by Germany, with a X% share.

From 2012 to 2021, the average annual rate of growth in terms of value to Japan stood at +X%. Exports to the other major destinations recorded the following average annual rates of exports growth: the United Arab Emirates (+X% per year) and Germany (+X% per year).

Export Prices by Country

In 2021, the average export price for medicaments of alkaloids or derivatives thereof amounted to $X per ton, waning by -X% against the previous year. Over the last nine-year period, it increased at an average annual rate of +X%. The most prominent rate of growth was recorded in 2017 an increase of X% against the previous year. The export price peaked at $X per ton in 2020, and then dropped in the following year.

There were significant differences in the average prices for the major export markets. In 2021, the country with the highest price was Japan ($X per ton), while the average price for exports to Democratic Republic of the Congo ($X per ton) was amongst the lowest.

From 2012 to 2021, the most notable rate of growth in terms of prices was recorded for supplies to the United Arab Emirates (+X%), while the prices for the other major destinations experienced more modest paces of growth.

Imports of Medicaments Of Alkaloids Or Derivatives Thereof

Imports into China

After four years of growth, purchases abroad of medicaments of alkaloids or derivatives thereof decreased by -X% to X tons in 2021. Overall, total imports indicated a remarkable increase from 2012 to 2021: its volume increased at an average annual rate of +X% over the last nine years. The trend pattern, however, indicated some noticeable fluctuations being recorded throughout the analyzed period. Based on 2021 figures, imports increased by +X% against 2016 indices. The growth pace was the most rapid in 2014 with an increase of X%. Over the period under review, imports of attained the peak figure at X tons in 2020, and then shrank slightly in the following year.

In value terms, imports of medicaments of alkaloids or derivatives thereof fell to $X in 2021. In general, total imports indicated a perceptible expansion from 2012 to 2021: its value increased at an average annual rate of +X% over the last nine-year period. The trend pattern, however, indicated some noticeable fluctuations being recorded throughout the analyzed period. Based on 2021 figures, imports increased by +X% against 2016 indices. The growth pace was the most rapid in 2014 when imports increased by X%. Imports peaked at $X in 2020, and then contracted in the following year.

Imports by Country

France (X tons), Germany (X tons) and Hong Kong SAR (X tons) were the main suppliers of imports of medicaments of alkaloids or derivatives thereof to China, together accounting for X% of total imports. The United States and Hungary lagged somewhat behind, together comprising a further X 2012 to 2021, the most notable rate of growth in terms of purchases, amongst the main suppliers, was attained by Hungary (with a CAGR of +X%), while imports for the other leaders experienced more modest paces of growth.

In value terms, the largest medicaments of alkaloids or derivatives thereof suppliers to China were France ($X), Germany ($X) and Hong Kong SAR ($X), with a combined X% share of total imports.

France, with a CAGR of +X%, saw the highest growth rate of the value of imports, among the main suppliers over the period under review, while purchases for the other leaders experienced mixed trend patterns.

Import Prices by Country

In 2021, the average import price for medicaments of alkaloids or derivatives thereof amounted to $X per ton, approximately mirroring the previous year. Overall, the import price recorded a perceptible contraction. The most prominent rate of growth was recorded in 2018 an increase of X%. Over the period under review, average import prices hit record highs at $X per ton in 2012; however, from 2013 to 2021, import prices stood at a somewhat lower figure.

There were significant differences in the average prices amongst the major supplying countries. In 2021, the country with the highest price was Hong Kong SAR ($X per ton), while the price for the United States ($X per ton) was amongst the lowest.

From 2012 to 2021, the most notable rate of growth in terms of prices was attained by France (+X%), while the prices for the other major suppliers experienced a decline.

Source: IndexBox Platform

Frequently Asked Questions (FAQ) :